3 More Businesses Could Start Growing, Selling Medical Cannabis as DPS Expands
Texas Compassionate Use Program expansion allows three more businesses to grow and sell medical cannabis. This increase in licensed operators aims to improve access to low-THC cannabis for qualifying patients. The program's expansion may reduce…
First Nations Protest on NS Highways Over Cannabis Raids
Indigenous cannabis sovereignty rights are central to recent protests on Nova Scotia highways over cannabis raids. These events highlight regulatory conflicts impacting medical cannabis access for Indigenous communities. Understanding these rights is…
Tilray Brands’ Strong Cannabis Sales and Upbeat Outlook Keep Analysts Bullish
Tilray Brands strong cannabis sales demonstrate significant cannabis market growth. This growth suggests improved product availability and market stability for patients. Robust sales may also encourage increased cannabis research funding.
FDA’s New Stance on Medicare CBD Coverage Program
The Medicare CBD coverage decision signals a shift in FDA policy allowing broader access for elderly patients. This hands-off approach may accelerate clinical experience with CBD in Medicare populations. However, it also raises concerns about product…
Roseville Approves Extended Cannabis Retail Hours
Extended cannabis retail hours in Roseville improve patient access to medical cannabis, especially for those with conflicting work schedules. This policy change supports better adherence to cannabis therapy regimens. Patients benefit from more flexible…
Health Expert to Lead Medical Cannabis Review | Irish Legal News
Ireland is conducting a medical cannabis policy review led by a health expert to improve patient access and clinical oversight. This review addresses regulatory frameworks and implementation challenges. The medical cannabis policy review may influence…
Politicians to Join Cape to Cape for Cannabis as Event Draws Near | Cannabiz
Political engagement cannabis industry events signal evolving regulatory frameworks impacting patient access and prescribing protocols. Understanding these developments helps clinicians anticipate shifts in treatment options. Political participation at…
Medicare Covers CBD Without FDA Approval and Faces a Lawsuit
Medicare CBD policy regulatory access is evolving as coverage occurs without FDA approval, prompting legal challenges. This shift affects patient access and insurance reimbursement for CBD products. Clinicians must monitor these developments closely to…
Anti-cannabis groups sue to block Medicare CBD program – GreenState
Legal challenges to Medicare CBD policy create uncertainty for elderly patients who may benefit from cannabinoid therapy. This litigation could delay or prevent access to CBD treatments under Medicare. Elderly patients face barriers to cannabinoid…
Two Central NY Convenience Stores Shut Down After Illegal Cannabis Sales, Police Say
Illegal cannabis sales at convenience stores in Central NY pose significant patient safety risks due to unregulated products. These enforcement actions highlight ongoing challenges in cannabis regulatory enforcement. Patients and clinicians must be aware…